AI assistant
Sending…
MANGOCEUTICALS, INC. — Director's Dealing 2024
Nov 12, 2024
34879_dirs_2024-11-12_c5576aeb-5ad2-443a-bf03-ae53203cbc46.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MANGOCEUTICALS, INC. (MGRX)
CIK: 0001938046
Period of Report: 2024-11-11
Reporting Person: JOHNSTON EUGENE M (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-11 | Common Stock | A | 25000 | — | Acquired | 38334 | Direct |
Footnotes
F1: Issued in consideration for serving as Chief Financial Officer of the Issuer. Issued under the registrant's 2022 Equity Incentive Plan, as amended. Exempt pursuant to Rule 16b-3.
More from MANGOCEUTICALS, INC.
Interim / Quarterly Report
2026
May 19
Annual Report
2026
Apr 1
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20
Regulatory Filings
2026
Feb 23
Regulatory Filings
2026
Feb 19
Delisting Announcement
2026
Feb 6
Capital/Financing Update
2026
Jan 23
Capital/Financing Update
2026
Jan 13
Regulatory Filings
2025
Dec 19